Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study Evaluating the Use of Systemic Chemotherapy and Chemohyperthemia Intraperitoneal Preoperatively (CHIP) and After Maximum Resection of Peritoneal Carcinomatosis Originating With Colorectal Cancer

NCT00769405 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00769405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00769405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study Evaluating the Use of Systemic Chemotherapy and Chemohyperthemia Intraperitoneal Preoperatively (CHIP) and After Maximum Resection of Peritoneal Carcinomatosis Originating With Colorectal Cancer
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
Not reported
Enrollment
264 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, primary peritoneal cavity cancer